Renalytix AI plc (RENX) - Cash Flow Conversion Efficiency

Latest as of December 2024: 4.746x

Based on the latest financial reports, Renalytix AI plc (RENX) has a cash flow conversion efficiency ratio of 4.746x as of December 2024. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (GBX-6.50 Million ≈ $-790.50 USD) by net assets (GBX-1.37 Million ≈ $-166.57 USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see how much is Renalytix AI plc worth for the company's overall valuation and market capitalisation.

Renalytix AI plc - Cash Flow Conversion Efficiency Trend (2012–2025)

This chart illustrates how Renalytix AI plc's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Renalytix AI plc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Renalytix AI plc ranked by their cash flow conversion efficiency. Explore Renalytix AI plc cash earnings quality to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Hercules Site Services PLC LSE:HERC	0.120x
Quintegra Solutions Limited NSE:QUINTEGRA	0.000x
GAMES BOX S.A. ZY-10 F:ZN6	-0.018x
PUNCH PUNK S.A. ZY-10 F:6K7	N/A
Cardiff Property PLC LSE:CDFF	-0.046x
Duearity AB ST:DEAR	0.036x
Challenger Energy Group PLC LSE:CEG	-0.008x
Global PVQ SE HM:QCE	3.126x

Annual Cash Flow Conversion Efficiency for Renalytix AI plc (2012–2025)

The table below shows the annual cash flow conversion efficiency of Renalytix AI plc from 2012 to 2025. View today's stock price for Renalytix AI plc for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-06-30	GBX-7.00 Million ≈ $-851.70	GBX-17.90 Million ≈ $-2.18K	2.557x	-33.30%
2024-06-30	GBX-7.85 Million ≈ $-955.60	GBX-30.11 Million ≈ $-3.66K	3.834x	+744.54%
2023-12-31	GBX20.76 Billion ≈ $2.53 Million	GBX9.43 Billion ≈ $1.15 Million	0.454x	+125.64%
2023-06-30	GBX18.45 Million ≈ $2.25K	GBX-32.67 Million ≈ $-3.98K	-1.771x	-67.09%
2022-06-30	GBX43.17 Million ≈ $5.25K	GBX-45.74 Million ≈ $-5.57K	-1.060x	-309.13%
2021-06-30	GBX95.10 Million ≈ $11.57K	GBX-24.63 Million ≈ $-3.00K	-0.259x	+7.42%
2020-06-30	GBX35.96 Million ≈ $4.38K	GBX-10.06 Million ≈ $-1.22K	-0.280x	-97.30%
2019-06-30	GBX28.17 Million ≈ $3.43K	GBX-3.99 Million ≈ $-485.95	-0.142x	-100.32%
2018-06-30	GBX-9.39K ≈ $-1.14	GBX-422.00K ≈ $-51.35	44.946x	+11298.75%
2016-12-31	GBX17.87 Billion ≈ $2.17 Million	GBX7.05 Billion ≈ $857.42K	0.394x	-6.04%
2015-12-31	GBX17.47 Billion ≈ $2.13 Million	GBX7.33 Billion ≈ $891.85K	0.420x	+30.71%
2014-12-31	GBX17.26 Billion ≈ $2.10 Million	GBX5.54 Billion ≈ $674.42K	0.321x	+4.07%
2013-12-31	GBX20.40 Billion ≈ $2.48 Million	GBX6.29 Billion ≈ $765.80K	0.308x	-28.02%
2012-12-31	GBX21.03 Billion ≈ $2.56 Million	GBX9.01 Billion ≈ $1.10 Million	0.429x	--

About Renalytix AI plc

LSE:RENX UK Health Information Services

Market Cap

$332.33K

GBX2.73 Billion GBX

Market Cap Rank

#31198 Global

#978 in UK

Share Price

GBX6.25

Change (1 day)

+1.63%

52-Week Range

GBX1.80 - GBX10.75

All Time High

GBX1220.00